This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Dianne L. Silvestri, MD; Lawrence Corey, MD; King K. Holmes, MD, PhD

JAMA. 1982;248(8):953-959.

Abstract
The efficacy and toxicity of topical applications of 30% idoxuridine in dimethyl sulfoxide, dimethyl sulfoxide alone, or saline in 96 recurrent and 39 first episodes of genital herpes simplex virus (HSV) infection were compared. Drug was applied to lesions four times daily for seven days. In recurrent episodes, the duration of viral shedding after beginning idoxuridine in dimethyl sulfoxide use was significantly shorter (0.6 days) than with dimethyl sulfoxide (1.4 days) or saline (2.0 days) (P<.05). In primary episodes, viral shedding lasted 2.6 days with idoxuridine in dimethyl sulfoxide and 8.4 days with dimethyl sulfoxide or saline. Idoxuridine in dimethyl sulfoxide had no effect in recurrent or primary HSV on duration of symptoms, new lesion formation, healing time, or risk of subsequent recurrence. Complications in patients given idoxuridine in dimethyl sulfoxide included local burning, generalized contact dermatitis, and vulvar carcinoma in situ. Thirty percent idoxuridine in dimethyl sulfoxide has no effect on clinical manifestations of genital HSV infection and may be hazardous.

(JAMA 1982;248:953-959)

Author Affiliations
From the Departments of Medicine (Dr Silvestri), Laboratory Medicine (Dr Corey), and Microbiology and Pediatrics (Dr Corey), Harborview Medical Center, Childrens Orthopedic Hospital, University of Washington Student Health Center, and the US Public Health Service Hospital (Dr Holmes), University of Washington, Seattle. Dr Silvestri is now with the University of California, Fresno.

Footnotes
Reprint requests to Virology Laboratory, G-810, Childrens Orthopedic Hospital, ZC-10, 4800 Sand Point Way NE, PO Box C-5371, Seattle, WA 98105 (Dr Corey).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes Simplex Virus Infection: Biology, Treatment, and Prevention
STRAUS et al.
ANN INTERN MED 1985;103:404-419.
ABSTRACT  

Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection
Mertz et al.
JAMA 1984;252:1147-1151.
ABSTRACT  

Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
COREY et al.
ANN INTERN MED 1983;98:958-972.
ABSTRACT  

Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention
LAWRENCE and HOLMES
ANN INTERN MED 1983;98:973-983.
ABSTRACT